Trastuzumab vs Ziprasidone Mesylate

## Trastuzumab vs Ziprasidone Mesylate: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Ziprasidone Mesylate**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Ziprasidone Mesylate — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Ziprasidone Mesylate — Small molecule.